Zhu Min, Feng Jianhua, Lucchinetti Eliana, Fischer Gregor, Xu Lin, Pedrazzini Thierry, Schaub Marcus C, Zaugg Michael
Institute of Anesthesiology, University Hospital Zurich, and Zurich Center of Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
Cardiovasc Res. 2006 Oct 1;72(1):152-62. doi: 10.1016/j.cardiores.2006.06.027. Epub 2006 Jul 6.
We tested whether ischemic postconditioning (IPostC) is protective in remodeled myocardium.
Post-myocardial infarct (MI)-remodeled hearts after permanent coronary artery ligation and one kidney one clip (1K1C) hypertensive hearts of male Wistar rats were exposed to 40 min of ischemia followed by 90 min of reperfusion. IPostC was induced by six cycles of 10 s reperfusion interspersed by 10 s of no-flow ischemia. Activation of reperfusion injury salvage kinases was measured using Western blotting and in vitro kinase activity assays.
IPostC prevented myocardial damage in both MI-remodeled and 1K1C hearts, as measured by decreased infarct size and lactate dehydrogenase release, and improved function. The reduction in infarct size and the recovery of left ventricular contractility achieved by IPostC was less in 1K1C hearts, but was unchanged in MI-remodeled hearts when compared to healthy hearts. In contrast, the recovery of inotropy was unaffected in 1K1C hearts, but was less in MI-remodeled hearts. Inhibition of the phosphatidylinositol 3-kinase (PI3K) pathway with LY294002 abolished the protective effects of IPostC on both disease models and healthy hearts. Western blot analysis in conjunction with in vitro kinase activity assays identified protein kinase B (PKB)/Akt but not p42/p44 extracellular-signal regulated kinase 1/2 (ERK1/2) as the predominant kinase in IPostC-mediated cardioprotection in remodeled hearts. IPostC increased phosphorylation of the PKB/Akt downstream targets eNOS, GSK3beta, and p70S6K in remodeled hearts.
Our results offer evidence that IPostC mediates cardioprotection in the remodeled rat myocardium primarily via activation of the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.
我们测试了缺血后处理(IPostC)对重塑心肌是否具有保护作用。
雄性Wistar大鼠在永久性冠状动脉结扎后发生心肌梗死(MI)重塑的心脏以及单肾单夹(1K1C)高血压心脏,先经历40分钟的缺血,随后再灌注90分钟。IPostC通过6个周期的10秒再灌注并穿插10秒的无血流缺血诱导产生。使用蛋白质印迹法和体外激酶活性测定法来检测再灌注损伤挽救激酶的激活情况。
通过梗死面积减小和乳酸脱氢酶释放量降低来衡量,IPostC可预防MI重塑心脏和1K1C心脏的心肌损伤,并改善心脏功能。与健康心脏相比,IPostC使1K1C心脏梗死面积的减小和左心室收缩力的恢复程度较低,但在MI重塑心脏中无变化。相反,1K1C心脏的心肌收缩力恢复不受影响,但在MI重塑心脏中恢复程度较低。用LY294002抑制磷脂酰肌醇3激酶(PI3K)途径可消除IPostC对两种疾病模型心脏和健康心脏的保护作用。蛋白质印迹分析结合体外激酶活性测定法确定,在IPostC介导的重塑心脏心脏保护中,蛋白激酶B(PKB)/Akt而非p42/p44细胞外信号调节激酶1/2(ERK1/2)是主要的激酶。IPostC可增加重塑心脏中PKB/Akt下游靶点内皮型一氧化氮合酶(eNOS)、糖原合成酶激酶3β(GSK3β)和核糖体蛋白S6激酶(p70S6K)的磷酸化水平。
我们的结果表明,IPostC主要通过激活PI3K-PKB/Akt再灌注损伤挽救激酶途径介导对重塑大鼠心肌的心脏保护作用。